Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

6.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

7.9K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

7.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Stopping Without Validation Data in Weakly Supervised Learning.

IEEE transactions on pattern analysis and machine intelligence·2026
Same author

Corrigendum to "Enhanced fluorescence imaging guided photodynamic therapy of sinoporphyrin sodium loaded graphene oxide" [Biomaterials 42 (2015) 16442].

Biomaterials·2026
Same author

Functional Characterisation of NF-YCs in True Leaf Biomass Accumulation.

Plants (Basel, Switzerland)·2026
Same author

Sex- and age-dependent physiological adaptation of captive père david's deer revealed by multi-omics analysis.

BMC genomics·2026
Same author

Nanotechnology-mediated precision delivery of mRNA.

Nature materials·2026
Same author

Correction to "Triphase Interface Synthesis of Plasmonic Gold Bellflowers as Near-Infrared Light Mediated Acoustic and Thermal Theranostics".

Journal of the American Chemical Society·2026

Related Experiment Video

Updated: Dec 28, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.9K

Endoplasmic Reticulum Targeting to Amplify Immunogenic Cell Death for Cancer Immunotherapy.

Hongzhang Deng1,2, Zijian Zhou2, Weijing Yang2

  • 1MOE key laboratory for analytical science of food safety and biology, College of Chemistry, Fuzhou University, Fuzhou 350108, China.

Nano Letters
|February 20, 2020
PubMed
Summary

This study introduces a novel photodynamic therapy (PDT) using nanoparticles that target the endoplasmic reticulum (ER) to enhance cancer immunotherapy by amplifying immunogenic cell death (ICD). This approach effectively eradicates primary and distant tumors via an abscopal effect.

Keywords:
Endoplasmic reticulum (ER) stressImmunogenic cell death (ICD)Photodynamic therapyabscopal effect

More Related Videos

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
07:33

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Published on: September 19, 2025

661
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.2K

Related Experiment Videos

Last Updated: Dec 28, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.9K
Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
07:33

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Published on: September 19, 2025

661
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.2K

Area of Science:

  • Biomedical Engineering
  • Cancer Research
  • Immunology

Background:

  • Photodynamic therapy (PDT) induces immunogenic cell death (ICD) via reactive oxygen species (ROS), but limited ROS diffusion hinders endoplasmic reticulum (ER) stress induction.
  • Effective ER stress induction is crucial for amplifying ICD and enhancing anti-tumor immune responses.

Purpose of the Study:

  • To develop an ER-targeting PDT strategy to overcome ROS diffusion limitations and enhance ICD.
  • To investigate the efficacy of ER-targeting nanoparticles in amplifying immunotherapy effects.

Main Methods:

  • Synthesis of reduction-sensitive Ds-sP nanoparticles loaded with an ER-targeting photosensitizer (TCPP-TER).
  • Evaluation of nanoparticle accumulation in the ER and ROS generation under near-infrared (NIR) laser irradiation.
  • Assessment of ER stress induction, ICD amplification, immune cell activation, and anti-tumor effects (primary and abscopal).

Main Results:

  • Ds-sP/TCPP-TER nanoparticles selectively accumulated in the ER.
  • NIR laser irradiation of nanoparticles induced localized ROS generation, ER stress, and amplified ICD.
  • Enhanced immune cell activation and significant eradication of primary and distant tumors were observed.

Conclusions:

  • The developed ER-targeting PDT strategy effectively amplifies ICD by overcoming ROS diffusion limitations.
  • This novel approach shows significant potential for enhancing cancer immunotherapy through combined primary tumor eradication and abscopal effects.